Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban.

Name: Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban.
Author: Tepper, Ping G

Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban. — المؤلف: Tepper, Ping G — PloS one 20190404

المؤلف: Tepper, Ping G
النشر: PloS one 20190404
الوصف: e0205989 p.
الموضوعات: Administration, Oral؛ Adolescent؛ Adult؛ Aged؛ Aged, 80 and over؛ Anti-Inflammatory Agents, Non-Steroidal؛ Anticoagulants؛ Atrial Fibrillation